DTIL

Precision BioSciences, Inc. DTIL

DTIL
Precision BioSciences, Inc. MGX
Metagenomi, Inc. Common Stock ALXO
ALX Oncology Holdings Inc. ADVM
Adverum Biotechnologies, Inc. ARTV
Artiva Biotherapeutics, Inc. STRO
Sutro Biopharma, Inc. GUTS
Fractyl Health, Inc. Common Stock RPTX
Repare Therapeutics Inc. ATYR
aTyr Pharma, Inc. CNTB
Connect Biopharma Holdings Limited

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode DTIL MGX ALXO ADVM ARTV STRO GUTS RPTX ATYR CNTB
6M 2.24 % 15.73 % 188.84 % 77.24 % 66.67 % 22.53 % 8.98 % 45.58 % -85.19 % 161.05 %
YTD 6.82 % -56.33 % -5.13 % -9.17 % -66.90 % -49.27 % 5.40 % 62.12 % -80.30 % 104.96 %
1Y 5.70 % -46.78 % -3.90 % -17.11 % -68.27 % -52.71 % 6.40 % 33.75 % -74.58 % 127.52 %
3Y -86.42 % -83.95 % -86.81 % -30.90 % -72.50 % -86.95 % -82.53 % -85.60 % -55.48 % 186.37 %
5Y -97.92 % -83.95 % -98.15 % -96.89 % -72.50 % -95.49 % -82.53 % -94.58 % -55.48 % -86.59 %
10Y -99.04 % -83.95 % -95.07 % -94.78 % -72.50 % -93.56 % -82.53 % -93.05 % -55.48 % -86.59 %
From the beginning -99.04 % -83.95 % -95.07 % -98.44 % -72.50 % -93.56 % -82.53 % -93.05 % -55.48 % -86.59 %

Dividend